We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cindrigo Holdings Limited | LSE:CHAL | London | Ordinary Share | Ordinary Shares |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.13 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
25/8/2017 08:15 | Buy those dips Sir, not easy to buy more than 50,000, forget in sub 1p These are going up, bear trap again | ny boy | |
25/8/2017 08:11 | I moved into ImmuPharma (IMM) which could be a 70 bagger by next March. | top tips | |
25/8/2017 08:07 | And of course you cannot buy zilch on the dip | love it | |
25/8/2017 07:51 | some meat on the bone now | sigora | |
25/8/2017 07:50 | £650k left to convert so around 60 million shares to be issued this is becoming a right pain. How many convertable notes are there I thought we cleared them all last week. | love it | |
25/8/2017 07:21 | This Note Facility will be used for general working capital purposes and to potentially support an acquisition or development of a project to complement the Company's US$3 million equity interest in the New York Wheel Project. | oilbuy | |
25/8/2017 07:20 | Looks like another aquisition is on the table. | oilbuy | |
24/8/2017 22:17 | Funds for other new ventures probably as last weeks cln's will take them to at least until end of Nov 17. I think they received £460K cash So they don't need funds for in-house expenses with these latest issue. All we need is an RN's stating another project on its way or new developer commence's and this will see 2p + in an instant. | sep800 | |
24/8/2017 21:13 | Hopefully we'll hear very soon some solid news. Saves speculating then 😃 | wolfcub | |
24/8/2017 16:02 | exactly monies maybe for ny wheel maybe another aquisition definately help if they said something, in the mean time another small wait for stock to clear now although most would have been forward sold | sigora | |
24/8/2017 15:59 | sigora - would be good if the company could clarify in an rns. perhaps money is needed to fund project/ keep % stake in the NYC project unchanged (new contractor/extended timeline etc additional costs) ? | mister md | |
24/8/2017 15:57 | well according to a poster on lse thats last of the clns now | sigora | |
24/8/2017 15:53 | mister d are there anymore clns to be issued ? guess this is whats keeping it down here | sigora | |
24/8/2017 15:45 | wolfclub completely agree, that always happens they made a fortune forward selling and now we are cleared for take off some good news would obviously help too! | turbotrader2 | |
24/8/2017 15:41 | Assuming forward sold like before then hopefully the brakes will be let off now and we can start heading north. | wolfcub | |
24/8/2017 15:37 | And after the RNS. | maytrees | |
24/8/2017 15:36 | someone is keen nice 1.5m buy | turbotrader2 | |
24/8/2017 15:28 | I tried a few times to buy on the dip but it was NT for anymore than a few£ | wolfcub | |
24/8/2017 15:26 | Managed to add at 1.15p. "Catching a falling knife"? Hopefully not but dyor. | maytrees | |
24/8/2017 15:24 | Now full offer to buy. | love it | |
24/8/2017 15:22 | Now back up it's easy to buy again around the mid price 1.175p | love it | |
24/8/2017 15:19 | On reflection if the notes were converted at 1.20p a share then buying more at 1.15p a share may be profitable - eventually. Hard to buy though as is not unusual. | maytrees | |
24/8/2017 15:18 | Same as before you could not get a quote to buy on the dip down online. Well I could not | love it | |
24/8/2017 15:16 | its not tragic! soon be gone those shares | turbotrader2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions